novartis

Why Indian pharma needs to elevate ESG for sustainable future

Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource challenges. Strengthening ESG performance can attract investments and promote susta

ByISB

AI is increasing demand for managers - and changing their skill sets

ByIESE Business School

Global pharma: Focus on core business, pure-play innovation

ByNaini Thaker

From Novartis' turnaround to everything you should know about studying abroad, here are our top reads of the week

ByForbes India

Novartis will start doing more fundamental research work in India: Vas Narasimhan

ByManu Balachandran

Novartis: Innovating for the world, from India

ByManu Balachandran

Inside Vasant 'Vas' Narasimhan's transformation of Novartis, and more

ByBrian Carvalho

Storyboard18 | Time is ripe to take advantage of the growing cult of Made-In-India CEOs

ByLloyd Mathias

Investing beyond borders: Risk or opportunity?

ByRamesh Sadhwani

FMCG Lessons for Pharma

ByISBInsight

Shared business values for greater impact : An innovative approach

ByGoodera

Forbes Global 2000: Powerful Companies, Compelling Stories

ByR Jagannathan

Bird flu: How myopic govt burnt bridges with vaccine makers

BySeema Singh

gst (3)donald-trump (2)international-monetary-fund (2)leadership (2)apple (1)art (1)au-small-finance-bank (1)automobile (1)bollywood (1)chatgpt (1)

Home

Novartis

Subscribe Now

novartis

Explore More Tags

Latest News